Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruchi Patel

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Future Oncology (London, England)|June 23, 2025
A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) - design and rationaleAndre R Kydd, Elias Chandran, Nicholas I Simon, et al.
JACC. Advances|June 18, 2026
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort StudySabin Filimon, Azin Ghamari, Azin Vakilpour, et al.
Research Square|June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancerAanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.
Thorax|February 2, 2018
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbationsDavid Mayhew, Nathalie Devos, Christophe Lambert, et al.
The New England Journal of Medicine|February 5, 2025
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>Karlo Perica, Nayan Jain, Michael Scordo, et al.
Cancer Discovery|July 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against CancerYong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, et al.
Cell|March 7, 2026
β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancerShan Liu, Puneeth Guruprasad, Ranjani Ramasubramanian, et al.
Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|July 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|June 23, 2025
A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) - design and rationaleAndre R Kydd, Elias Chandran, Nicholas I Simon, et al.
JACC. Advances|June 18, 2026
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort StudySabin Filimon, Azin Ghamari, Azin Vakilpour, et al.
Research Square|June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancerAanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.
Thorax|February 2, 2018
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbationsDavid Mayhew, Nathalie Devos, Christophe Lambert, et al.
The New England Journal of Medicine|February 5, 2025
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>Karlo Perica, Nayan Jain, Michael Scordo, et al.
Cancer Discovery|July 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against CancerYong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, et al.
Cell|March 7, 2026
β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancerShan Liu, Puneeth Guruprasad, Ranjani Ramasubramanian, et al.
Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|July 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Pageof 9